Biotech News

Nearly 40% of Women Say They were Misdiagnosed During Perimenopause, National Survey Reveals

biote Corp (BTMD)biote Corp2026-06-25 13:46 ESTCompany update

Perimenopause survey reveals widespread misdiagnoses undermining women’s health, with women turning to Google instead of doctors for information IRVING, Texas--( BUSINESS WIRE )--A groundbreaking national survey from Biote , a leading innovator advancing the healthspan of patients’ lives by

Open original release

Related news

biote Corp

biote is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States